Skip to main content
. 2022 Jan 20;22:70. doi: 10.1186/s12879-021-07019-1

Table 3.

Patient reported outcomes and quality of life

EORTC QLQC30 or PedsQL Hesitancy scale PRO CTCAE Toxicitya
Vaccine dose 1 (− 7) X  X 
D7 (± 1) post dose 1 X  X
Vaccine dose 2 X 
D7 (± 1) post dose 2 X  X 
3 M post dose 2 X  X 

D day, M month, EORTC QLQ European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire, PRO CTCAE Patient Reported Outcomes Common Terminology Criteria for Adverse Events

aMedical record review